Myocardial delivery of a mitochondria-targeted H2S donor restores bioenergetics and cardiac performance in diabetic cardiomyopathy
Diabetic cardiomyopathy (DCM) is a major substrate for heart failure in diabetes and remains without effective therapies to halt its progression. Mitochondrial dysfunction and impaired myocardial bioenergetics are increasingly recognised as key contributors to DCM pathogenesis. Hydrogen sulfide (H₂S) is an endoge...